Scribd
Upload
75 views

Case Presentation: Male Hypogonadism

A 52-year-old male presented with irritability, fatigue, behavioral disorders, sexual dysfunction, and gynecomastia. Laboratory tests revealed hypergonadotropic hypogonadism. Genetic analysis showed a 47,XXY karyotype, confirming a diagnosis of Klinefelter syndrome. He was started on testosterone injections and psychiatric medications. Long-term risks for those with Klinefelter syndrome include increased risks of germ cell tumors, breast cancer, osteoporosis, and infertility.

Uploaded by

didu91
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
75 views

Case Presentation: Male Hypogonadism

A 52-year-old male presented with irritability, fatigue, behavioral disorders, sexual dysfunction, and gynecomastia. Laboratory tests revealed hypergonadotropic hypogonadism. Genetic analysis showed a 47,XXY karyotype, confirming a diagnosis of Klinefelter syndrome. He was started on testosterone injections and psychiatric medications. Long-term risks for those with Klinefelter syndrome include increased risks of germ cell tumors, breast cancer, osteoporosis, and infertility.

Uploaded by

didu91
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 17

Case presentation

Male hypogonadism

S.P, 52 y, male

Chief complaints

irritability,
fatigue, behavioral disorders, sexual disfunctions (libido , erectile dysfunction) gynecomastia

Medical history

Infertility

Hyperprolactinemia
Absence of the secundary sexual characteristics

diagnosis of hypogonadism - treatement with Testosterone i.m.

Arterial hypertension: Amlodipin 10 mg/day, Atenolol 50 mg/day, Lisinopril 10mg/day

Depression: Cipralex 10 mg/day, Valproic ac. 1tb/day

Physical examination
Characterisitic features:

low muscle mass and strength, reduced facial, axillary and troncular hair growth, pubic hair growth - horizontal pubic insertion (triangular),

ginoid habitus, with biacromial diameter smaller than bitrohanterian

bilateral gynecomastia, bilateral retractile testes,


V=8

mL, firm, painless, with peno-orchitis dissociation,

L- 181 cm, Arm Span 187 cm BMI= 32.9 kg/m2

Physical examination

Laboratory findings

Blood count normal Glycemia a jeun: 104 mg/dL Total cholesterol: 227 mg/dL (N<199) Triglycerides: 120 mg/dL (N <149) Uric acid: 4.58 mg/dL (N: 2.6-7.2) Creatinine: 0.91 mg/dL (N: 0.6-1.3) Urea: 18.3 mg/dL (N: 10-50) AST, ALT, Na, K - normal PSA=1.525 (N < 4ng/ml)

Hormonal assesment - 2007


FSH= 38,7 UI/L LH= 22,5 UI/L Testosteron= 1,98 ng/dL PRL= 15 ng/mL Hypergonadotropic hypogonadism

Genetic analysis

47 XXY

Paraclinical examinations

Lombar spine x ray L5 vertebral fragility fracture

Semen analysis - azoospermia

HORMONAL ASSESSMENT - 2011


Pituitary hormone level at baseline
PRL= 8.157 N 3.6-16.3ng/ml LH = 0.18 N 1.7-11.2UI/ml FSH= 1.06 N 2.1-18.6UI/ml Testosteron = 5.776 VN 2.62-8.7ng/dl azoospermia

Appropriate peripheral hormone(s) or parameter

Interpretation
normal

hypogonadism (primary, under treatement) euthyroidism

TSH = 1.658 mIU/ml

fT4 =15.22 VN 12-22pmol/l Ca total 9,06 mg/dl Phosphorus- 2,44 mg/dl

(N: 0. 27-4.2)
PTH=80,465 N 15-65ng/dl secondary hyperparathyroidism

Final diagnosis: Klinefelter Syndrome Hypergonadotropic hypogonadism Gr. II Arterial Hypertension Depression Gr.I Obesity

Differential diagnosis

Primary hypogonadism:

Bilateral anorchia Enzymatic defects in synthesis of testosterone, pure gonadal dysgenesis, Incomplete androgen insensitivity,

Central hypogonadysm

GnRH deficiency Mutations in the leptin or leptin R Syndromes with mental retardation and hypogonadism

Leydig cells hypoplasia


Noonan syndrome Uncorrected cryptorchidism Myotonic Dystrophy "Sertoli cell only "

Isolated LH or FSH deficiency


Pituitary insufficiencies

Acquired forms :

central hypothalamic-pituitary lesions suppression of gonadotropins by:


Acquired Disorders:

hyperprolactinemia, administration of GnRH, sex steroids in high doses, opioids

gonadal irradiation, infectious diseases, trauma, autoimmune processes, drugs, chronic systemic disease.

chronic disease, type II diabetes.

Treatment

Psychiatric counseling Nebido (testosterone undecanoat) 1000 mg i.m. 1 f/3 months

Monitoring: PSA, blood counts

Risendros 35 mg 1 tb/week

Treatment

Contraindications to treatment with androgens:

high risk: prostate cancer metastatic breast cancer


moderate risk: - prostatic node, - severe benign prostatic hyperplasia, - inexplicably high levels of PSA, - polycythemia (hematocrit > 50%), - severe obstructive sleep apnea, - severe congestive heart failure (NYHA III/IV).

Possible side effects of androgen replacement therapy


polycythemia, acne, subclinical prostate cancer, enlargement of metastatic prostate cancer, gynecomastia, breast cancer, reduction of spermatogenesis and fertility, alopecia, induction/worsening of obstructive sleep apnea, impaired liver function and decreased HDL - c, pain at the injection site

Evolution and prognosis


Increased risk of:

Germ tumor cells Breast cancer (20x) Osteoporosis Infertility is definitive

Evolution and prognosis


Klinefelter sy. may be associated with: chronic lung disease (emphysema, chronic bronchitis) mediastinal tumors, lung cancer non Hodgkin lymphoma, leukemia varicose veins cerebrovascular disease obesity, autoimmune thyroiditis, hypothyroidism, diabetes mellitus, peptic ulcer, taurodontism

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy